These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


570 related items for PubMed ID: 23600605

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals.
    Gutiérrez O, Juan C, Cercenado E, Navarro F, Bouza E, Coll P, Pérez JL, Oliver A.
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4329-35. PubMed ID: 17938181
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Beta-lactam resistance mechanisms in Pseudomonas aeruginosa strains causing bloodstream infections: comparative results between Brazilian and American isolates.
    Fehlberg LC, Xavier DE, Peraro PP, Marra AR, Edmond MB, Gales AC.
    Microb Drug Resist; 2012 Aug; 18(4):402-7. PubMed ID: 22455540
    [Abstract] [Full Text] [Related]

  • 48. Expression of ampC, oprD, and mexA, outer membrane protein analysis and carbapenemases in multidrug resistant clinical isolates of Pseudomonas aeruginosa from Egypt.
    El-Mahdy TS.
    J Chemother; 2014 Dec; 26(6):379-81. PubMed ID: 24867184
    [No Abstract] [Full Text] [Related]

  • 49. PME and Other ESBL-Positive Multiresistant Pseudomonas aeruginosa Isolated from Hospitalized Patients in the Region of Kurdistan, Iraq.
    van Burgh S, Maghdid DM, Ganjo AR, Mansoor IY, Kok DJ, Fatah MH, Alnakshabandi AA, Asad D, Hammerum AM, Ng K, Klaassen C, Goessens WHF.
    Microb Drug Resist; 2019 Dec; 25(1):32-38. PubMed ID: 30067166
    [Abstract] [Full Text] [Related]

  • 50. Molecular epidemiology of Pseudomonas aeruginosa isolated from infected ICU patients: a French multicenter 2012-2013 study.
    Slekovec C, Robert J, van der Mee-Marquet N, Berthelot P, Rogues AM, Derouin V, Cholley P, Thouverez M, Hocquet D, Bertrand X.
    Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):921-926. PubMed ID: 30826996
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Mechanisms of carbapenem resistance in cephalosporin-susceptible Pseudomonas aeruginosa in China.
    Zeng ZR, Wang WP, Huang M, Shi LN, Wang Y, Shao HF.
    Diagn Microbiol Infect Dis; 2014 Mar; 78(3):268-70. PubMed ID: 24359931
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Genetic and phenotypic variations of a resistant Pseudomonas aeruginosa epidemic clone.
    Hocquet D, Bertrand X, Köhler T, Talon D, Plésiat P.
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1887-94. PubMed ID: 12760863
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Changes in the resistance and epidemiological characteristics of Pseudomonas aeruginosa during a ten-year period.
    Feng W, Huang Q, Wang Y, Yuan Q, Li X, Xia P, Sun F.
    J Microbiol Immunol Infect; 2021 Apr; 54(2):261-266. PubMed ID: 31628088
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Spread of efflux pump-overexpressing, non-metallo-beta-lactamase-producing, meropenem-resistant but ceftazidime-susceptible Pseudomonas aeruginosa in a region with blaVIM endemicity.
    Pournaras S, Maniati M, Spanakis N, Ikonomidis A, Tassios PT, Tsakris A, Legakis NJ, Maniatis AN.
    J Antimicrob Chemother; 2005 Oct; 56(4):761-4. PubMed ID: 16115825
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 29.